期刊文献+

HBs和HCVc基因双顺反子质粒在BALB/c小鼠体内的分布

Tissure distribution in BALB/c of bicistronic plasmids HCV with core and HBV preS_2S
原文传递
导出
摘要 采用注射含双顺反子质粒后,PCR法扩增不同组织中HBsAg和HCVc基因,同时检测HBV和HCV抗体应答水平.研究注射基因免疫用双顺反子质粒在小鼠组织中的分布.pcDNA3.0BApc154S2S 1次注射BALB/c小鼠后,24 h内主要分布于血液、肝、脾、骨髓、淋巴结、注射部位肌肉、肺和肾等含血液丰富的组织中.注射后2 d主要在骨髓、血液和注射部位肌肉中存在.7 d后仅在注射部位肌肉中能检测出来,并可持续到第9周.组织切片镜检质粒注射初期肌肉细胞轻度浊肿,随后肌膜细胞轻度增生,未见其它明显的组织病理学变化.质粒多次免疫BALB/c小鼠未见明显的临床症状和病理组织学变化.质粒在小鼠体内不同组织存在时间不一致. DNA immunization can induce humoral and cellular immune responses to against a range of viral pathogens. The results show HCV core and HBV preS2S can induce strong immune responds in DNA immunization. After muscular adminstration was performed, pc154S2S plasmid DNA was detected initially in all highly vascularized tissues. Two days latter, they mainly stayed at span, blood and injceted muscles; Seven days latter, the pc154S2S only can be found in the injected muscles, it can be kept for nine weeks. Intramuscular injections of plasmid has no clinical symptom and histopathogical damages in the injection sites.
出处 《云南大学学报(自然科学版)》 CAS CSCD 北大核心 2006年第3期267-270,276,共5页 Journal of Yunnan University(Natural Sciences Edition)
基金 云南省自然科学基金资助项目(2001C0072M2004C0070M)
关键词 DNA疫苗 双顺反子质粒 组织分布 DNA immunization bicistronic histopathogical damages in the injection sites plasmid tissure distribution
  • 相关文献

参考文献15

  • 1TUTEJAR.DNA vaccines:a ray of hope[J].Crit Rev Biochem Mol Biol,1999,34(1):1-24.
  • 2Nogales Espert A.A view to the future of vaccines[J].An R Acad Nac Med (Madr),2005,122(1):171-184.
  • 3CUI Z.DNA vaccine[J].Adv C enet,2005,54:257-289.
  • 4LIU M A,ULMER J B.Human clinical trials of plasmid DNA vaccines[J].Adv Genet,2005,55:25-40.
  • 5周东霞,王杨,孙明,蒋国润,黄小琴,俞建昆,褚嘉祐.HIV-1C亚型DNA疫苗诱导小鼠免疫反应的研究[J].云南大学学报(自然科学版),2005,27(5):451-456. 被引量:1
  • 6萨姆布鲁克J 弗里奇EF 曼尼阿蒂斯T 金冬雁 黎孟枫 侯云德等译.分子克隆实验指南[M].北京:科学出版社,1992..
  • 7BAROUCH D H.Rational design of gene-based vaccines[J].J Pathol,2006,208(2):283-289.
  • 8WOLFF J A,BUDKER V.The mechanism of naked DNA uptake and expression[J].Adv Genet,2005,54:3-20.
  • 9DONNELLY J J,WAHREN B,LIU M A.DNA vaccines:progress and challenges[J].J Immunol,2005,175(2):633-639.
  • 10SUEZANNE E P.Plasmid DNA Malaria vaccine:Tissure distribution and safety studies in mice and rabbits[J].Human Gene therapy,1999,10:741-758.

二级参考文献22

  • 1李大勤,郑锡文,张桂云,田春桥,曲书泉.中国云南省瑞丽等地艾滋病病毒I型C亚型的分布研究[J].中华流行病学杂志,1996,17(6):337-339. 被引量:5
  • 2萨姆布鲁克J 拉塞尔DW 黄培堂 王嘉玺 朱厚础 译.分子克隆实验指南(第3版)[M].北京:科学出版社,2002.2-140.
  • 3NABEL G J. Challenges and opportunities for development of an AIDS vaccine[J]. Nature,2001,410:1 002-1 007.
  • 4MCADAM S,P Kaleebu P, KRAUSA P, et al. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV - 1infection[J]. AIDS, 1998,12:571-579.
  • 5Zur Megede, CHEN M C, BOE B, et al. Increased expressed and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene[J].J Virol,2000,74:2 628- 2635.
  • 6QIU J T, SONG R, DETTENHOFER M, et al. Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune response [J]. J Virol, 1999, 73: 9 145-9152.
  • 7MWAU M, MCMICHAEL A J. A review of vaccines for HIV prevention[J] .J of Gene Med,2003,5:3-102.
  • 8KAUFNANJ,JINGJ.ChinaandAIDS- the time to act is now[J]. Science, 2002,296: 2 339-2 340.
  • 9MCCUTCHAN F E. Understanding the genetic diversity of HIV - 1[J] .AIDS,2000,14(3) :31-44.
  • 10PEETERS M, SHARP P M. Genetic diversity of HIV - 1:the moving target[J]. AIDS,2000,14:129-140.

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部